Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOOKAD Soluble VTP for Localized Intermediate Risk Prostate Cancer
NCT03315754Phase 2Completed
- Sponsor
- Steba Biotech
- Start
- Oct 2017
- Primary completion
- Nov 2020
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of talaporfin sodium in prostate cancer (PCa), sponsored by Steba Biotech. Started Oct 2017; status: completed.
02
Drugs
talaporfin sodium
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03315754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03315754.